RESUMO
ObjectiveTo investigate the changes of differential metabolites in the serum of mice at different stages of bleomycin sulfate(BLM)-induced pulmonary fibrosis modeling and administration, and the mechanism of Wenfei Huaxian granules(WHG)against idiopathic pulmonary fibrosis. MethodMice were randomly divided into control group, control group of 14 days, model group, model group of 14 days, low-dose WHG group and high-dose WHG group. BLM(0.04 U per mouse)was injected into the trachea of mice in the model group, model group of 14 days, low-dose WHG group and high-dose WHG group, and sterile normal saline was injected into the trachea of mice in the control group and control group of 14 days. Mice of low-dose WHG group and high-dose WHG group were given different doses of WHG by gavage every day after injection of BLM, and mice of control group, control group of 14 days, model group and model group of 14 days were given sterile water by gavage every day. The peripheral blood of mice in the control group of 14 days and model group of 14 days were taken to prepare serum after injection of BLM for 14 days, and the peripheral blood and other materials of mice in the other groups were taken after continuous administration for 28 days. The bronchoalveolar lavage fluid(BALF)was collected for leucocyte differential count, the pathological examination and hydroxyproline(HYP)content determination of lung tissues of mice were performed, and the small molecule metabolites in serum samples of mice in each group were determined by ultra-high performance liquid chromatography-mass spectrometry(UHPLC-MS). Principal component analysis(PCA)and orthogonal partial least squares-discriminant analysis(OPLS-DA)were conducted to screen differential metabolites and their biological functions were analyzed. ResultCompared with the control group, a large number of continuous fibrotic foci appeared in the lung tissue of mice in the model group, the alveolitis score, fibrosis degree score and HYP content increased significantly(P<0.01), and the total number of leukocytes, macrophages and lymphocytes in BALF increased significantly(P<0.05). A total of 33 differential metabolites were screened between the control group of 14 days and model group of 14 days, mainly lipid metabolites, which were mainly involved in oxidative damage and inflammatory process. A total of 34 differential metabolites, mainly amino acid metabolites, were screened between the control group and model group, mainly involving nucleic acid damage and inflammatory process. Compared with the model group, the HYP content, fibrosis score and alveolitis score in the lung tissue of mice from high-dose WHG group decreased significantly(P<0.05, P<0.01), and the total number of lymphocytes in BALF decreased significantly(P<0.05). Compared with the model group, 27, 40 differential metabolites were identified in the serum of mice from the low-dose WHG group and high-dose WHG group separately. There were totally 9 common differential metabolites between the model group and low-dose WHG group/high-dose WHG group, which mainly involved in the metabolic pathways of inflammation related lipids metabolism, arginine and tryptophan metabolism, and the change trends in low-dose WHG group and high-dose WHG group were significantly back-regulated compared with the model group. ConclusionWHG can alleviate BLM-induced pulmonary fibrosis, collagen deposition and inflammatory reaction in mice, and its anti-fibrotic effect may be related to the adjusting of inflammatory factors, nitric oxide and oxidative stress related metabolic pathways.
RESUMO
ObjectiveIn this study, based on ultra-high performance liquid chromatography-mass spectrometry(UHPLC-MS/MS) and high-throughput transcriptome sequencing technology(RNA-seq), we investigated the mechanism of Yishen Huashi granules in regulating serum metabolites and renal messenger ribonucleic acid(mRNA) expression to improve diabetic kidney disease(DKD). MethodSD rats were randomly divided into normal group , model group and Yishen Huashi granules group, with 8 rats in each group. The rat model of DKD was established by intraperitoneal injection of streptozotocin. Yishen Huashi granules group was given 5.54 g·kg-1·d-1 of Yishen Huashi granules by gavage, and the normal group and the model group were given the same amount of normal saline for 6 weeks. During the experiment, the body weight and blood glucose of rats were monitored, and the rats were anesthetized 24 hours after the last administration, blood was collected from the inferior vena cava, serum was separated, and renal function, blood lipid, and inflammatory indicators were detected. Kidney tissue of rats was fixed in neutral paraformaldehyde, and stained with hematoxylin-eosin(HE), Masson and periodic acid-Schiff(PAS) to observe the renal pathological changes. UHPLC-MS/MS and RNA-seq were used to identify the changes of serum metabolism and the differences of renal mRNA expression, and real time fluorescence quantitative polymerase chain reaction(Real-time PCR) and Western blot were used to detect the differential mRNA and protein expression in renal tissue to explore the common expression mechanism. ResultCompared with the normal group, rats in the model group showed a decrease in body weight, a significant increase in blood glucose, urinary microalbumin to urinary creatinine ratio(UACR), blood urea nitrogen(BUN), cystatin-C(Cys-C), β2-microglobulin(β2-MG), interleukin-6(IL-6), triglyceride(TG) and total cholesterol(TC), and a significant decrease in total superoxide dismutase(T-SOD)(P<0.01). After the intervention of Yishen Huashi granules, all the indexes were improved to different degrees in rats(P<0.05, P<0.01). Compared with the normal group, the model group showed renal mesangial stromal hyperplasia, fibrous tissue hyperplasia and tubular vacuolar degeneration. Compared with the model group, the renal pathology of rats in Yishen Huashi granules group was improved to a certain extent. A total of 14 target metabolites and 96 target mRNAs were identified, the target metabolites were mainly enriched in 20 metabolic pathways, including sphingolipid metabolism, glycerophospholipid metabolism, and the biosynthesis of phenylalanine, tyrosine and tryptophan. The target mRNAs were enriched to obtain a total of 21 differential mRNAs involved in the TOP20 pathways closely related to glycolipid metabolism. A total of 6 pathways, glycerophospholipid metabolism, arachidonic acid metabolism, purine metabolism, primary bile acid biosynthesis, ascorbic acid and uronic acid metabolism, and galactose metabolism, were enriched by serum differential metabolites and renal differential mRNAs, among them, there were 7 differential metabolites such as phosphatidylethanolamine(PE) and 7 differential mRNAs such as recombinant adenylate cyclase 3(ADCY3). Seven differential metabolites had high predictive accuracy as verified by receiver operating characteristic(ROC) curve, and the results of Real-time PCR and Western blot were highly consistent with the sequencing results. ConclusionYishen Huashi granules can reduce UACR, BUN and other biochemical indexes, correct the disorder of glucose and lipid metabolism, and improve renal function of DKD rats. And its mechanism may be related to the regulation of the level of PE and other blood metabolites, and expression of Phospho1 and other mRNAs in the kidney, of which six pathways, including glycerophospholipid metabolism, may play an important role.